Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 235
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01610687 | A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis | ||
| NCT05122650 | A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) | ||
| NCT00097708 | Experimental Medication For the Treatment of Generalized Anxiety Disorder | ||
| NCT02238925 | An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients | ||
| NCT04745026 | Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder | ||
| NCT05126433 | Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors | ||
| NCT01964547 | A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients | ||
| NCT04006925 | Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate | ||
| NCT01599234 | A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis | ||
| NCT02053272 | A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes | ||
| NCT06043427 | Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma | ||
| NCT00132873 | Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy | ||
| NCT02565108 | A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol | ||
| NCT03101241 | A Phase 2 RCT Study of CX-8998 for Essential Tremor | ||
| NCT05636111 | Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer | ||
| NCT00423605 | Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. | ||
| NCT05558124 | CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML | ||
| NCT01610713 | An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis | ||
| NCT03904251 | CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia | ||
| NCT04526288 | CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease | ||
| NCT02091375 | Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) | ||
| NCT03825796 | CPX-351 Plus Enasidenib for Relapsed AML | ||
| NCT02257684 | A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar) | ||
| NCT02953548 | Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7) | ||
| NCT04567784 | Neuroimaging and CBD for Opiod Use Disorder | ||
| NCT04195945 | CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients | ||
| NCT04485104 | Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures | ||
| NCT00371137 | A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia | ||
| NCT03335267 | Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia | ||
| NCT01812603 | A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma | ||
| NCT01886105 | Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma | ||
| NCT00358501 | Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients | ||
| NCT02544763 | A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) | ||
| NCT05850676 | Disentangling the Role of Depression in Hypersomnia | ||
| NCT05656248 | Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms | ||
| NCT05288283 | Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures | ||
| NCT00514995 | Sodium Oxybate in the Treatment of Binge Eating Disorder | ||
| NCT02325011 | An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience. | ||
| NCT01610700 | An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients | ||
| NCT03848832 | Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome | ||
| NCT07102381 | A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer | ||
| NCT00628498 | Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study | ||
| NCT05169307 | CPX-351 Real-World Effectiveness and Safety Study | ||
| NCT01322464 | Study to Assess Food Effect on Sativex Bioavailability | ||
| NCT05826756 | Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting | ||
| NCT04894591 | To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) | ||
| NCT01217112 | GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes | ||
| NCT03878199 | Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms | ||
| NCT04038437 | A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML | ||
| NCT02348593 | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" |
